Prof. Dr. med. Horst Helbig
ophthalmology
ophthalmology
Overview
Country, City
Germany, Regensburg
Health facility
University Hospital Regensburg
Medical unit
Department of ophthalmology
5.0 on Google
The data collected based on
2
patient reviews on Google
About the doctor
Skills & Expertise
degeneration
macular degeneration
agerelated macular degeneration
ophthalmology
retinopathy
retinal detachment
vitrectomy
surgery
diabetic
glaucoma
epithelial cells
retina
eye
diabetic retinopathy
neovascularization
ciliary epithelial cells
antivegf
ciliary body
retinal pigment
pigmented ciliary
maculopathy
choroidal neovascularization
retinal capillary pericytes
vision
epithelial detachment
intraocular pressure
photodynamic therapy
vitreous
retinal detachment surgery
retinal pigment epithelium
endothelial growth factor
optical coherence tomography
vitreoretinopathy
muscle cells
diabetic maculopathy
eye injuries
antivegf therapy
ciliary epithelium
bone marrow
plana vitrectomy
optic disc
cataract surgery
intravitreal 5fluorouracil
visual loss
macular neovascularization
choroidal osteoma
openangle glaucoma
endophthalmitis
choroid
choroidopathy
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine
- Obtaining a license for medical practice
- Defense of the dissertation
- Long-term research stays in the USA
- Obtaining specialization in ophthalmology
- Habilitation and a teaching license
Experience
- Senior Physician in St. Gallen and Zurich
- Director of the Department of ophthalmology at the University Hospital Regensburg
Awards & Memberships
- 1999 Member of the board of the Retinological Society
- 2015 President of the German Ophthalmological Society
- Press and Media Spokesman for the German Society of Ophthalmology
Languages
English
German
Publications
Descemet's membrane endothelial keratoplasty is the predominant keratoplasty procedure in Germany since 2016: a report of the DOG-section cornea and its keratoplasty registry.
21 May, 2024
[Long-term outcome of macular neovascularization secondary to choroidal osteoma with and without intravitreal anti-VEGF(vascular endothelial growth factor)- treatment].
3 September, 2023
Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-TherapieLong-term outcome of macular neovascularization secondary to choroidal osteoma with and without intravitreal anti-VEGF(vascular endothelial growth factor)- treatment
September, 2023
Location
Franz-Josef-Strauß-Allee, 11, 93053 Regensburg, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Horst Helbig?
The primary specialization of the doctor is ophthalmology .
What is the experience of the specialist?
Prof. Dr. med. Horst Helbig has been practicing for more than 25 years.
Prof. Dr. med. Horst Helbig
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Horst Helbig